BioHarvest Sciences(BHST.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
BioHarvest Sciences
BHST.US
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.
540.12 B
BHST.USMarket value -Rank by Market Cap -/-

Financial Score

22/01/2026 Update
C
Personal Care ProductsIndustry
Industry Ranking26/55
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-200.22%E
    • Profit Margin-36.33%E
    • Gross Margin61.43%A
  • Growth ScoreA
    • Revenue YoY45.88%A
    • Net Profit YoY30.86%B
    • Total Assets YoY36.27%A
    • Net Assets YoY86.88%A
  • Cash ScoreC
    • Cash Flow Margin-275.26%D
    • OCF YoY45.88%A
  • Operating ScoreA
    • Turnover1.07A
  • Debt ScoreE
    • Gearing Ratio78.02%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    BioHarvest Sciences Invests in New Corporate Campus and Expanded Manufacturing Facility

    Bioharvest Sciences Inc. has announced plans for significant expansion, following a successful year of growth. The company raised approximately $30.8 million through various financing methods and will invest in a new corporate campus and expanded manufacturing facility, including a 100-ton manufacturing footprint. These investments aim to support its growth strategy and enhance operational efficiency in its direct-to-consumer products and CDMO services.

    Reuters·
    US
    BHST
    +9.49%
    Reuters·
    US
    BHST
    +9.49%

    BioHarvest Sciences Secures $1.6 Million Grant from Israeli Innovation Authority

    BioHarvest Sciences Inc. has received a $1.6 million non-dilutive grant from the Israeli Innovation Authority to advance its Botanical Synthesis™ platform. The funding will aid in integrating AI tools, expanding bioreactor capacity, and enhancing manufacturing functions. The grant is part of the IIA’s Bio-Convergence program and is contingent on future project revenues, with no equity issued.

    Reuters·
    US
    BHST
    +9.49%
    Reuters·
    US
    BHST
    +9.49%

    Bioharvest Sciences Reports Balanced Earnings Call Insights

    Bioharvest Sciences reported a 39% revenue increase to $9.1M, driven by VINIA products. The CDMO segment grew 722%, generating $0.7M. A $19.9M equity financing strengthened the balance sheet. Gross profit rose 50% to $5.6M, with margins at 61%. Despite net losses of $2.5M, operating expenses increased to $6.5M. The company anticipates Q4 revenues of $9M-$9.5M and aims for breakeven EBITDA, focusing on direct-to-consumer and CDMO expansion.

    Tip Ranks·
    US
    BHST
    +9.49%
    Tip Ranks·
    US
    BHST
    +9.49%

    BioHarvest Sciences Inc. to Attend Craig-Hallum Alpha Select Conference

    BioHarvest Sciences Inc. will participate in the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025, at the Sheraton New York Times Square Hotel. CEO Ilan Sobel will engage in one-on-one meetings with institutional investors to discuss the company's growth in its consumer and CDMO divisions, the success of its VINIA capsule business, and new product launches, including VINIA Daily Chews 2X Formula and VINIA Blood Flow Hydration Solution.

    Reuters·
    US
    BHST
    +9.49%
    Reuters·
    US
    BHST
    +9.49%

    Bioharvest Sciences Inc. to Release Third Quarter 2025 Results

    Bioharvest Sciences Inc. will announce its third quarter 2025 financial results after market close on November 13, 2025. An investor conference call and webcast will follow at 4:30 p.m. Eastern time to discuss the results. The webcast can be accessed via the company's website.

    Reuters·
    US
    BHST
    +9.49%
    Reuters·
    US
    BHST
    +9.49%
    © 2026 Longbridge｜Disclaimer